ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CING Cingulate Inc

0.8791
-0.0009 (-0.10%)
Apr 19 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Cingulate Inc CING NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0009 -0.10% 0.8791 16:30:11
Open Price Low Price High Price Close Price Prev Close
0.8417 0.8263 0.899899 0.8791 0.88
more quote information »

Recent News

Date Time Source Heading
4/16/202417:00GLOBECingulate to Participate in Planet MicroCap Showcase: Vegas..
4/01/202408:00GLOBECingulate Inc. Reports Fourth Quarter and Full Year 2023..
3/19/202416:45GLOBECingulate to Participate in Benzinga All Live Access Event
3/06/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202406:45GLOBECingulate to Attend DCAT Week 2024 in New York City
2/26/202407:00EDGAR2Form 8-K - Current report
2/14/202417:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/13/202406:50EDGAR2Form 8-K - Current report
2/13/202406:45GLOBECingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff..
2/09/202409:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/09/202406:28EDGAR2Form SC 13D/A - General statement of acquisition of..
2/06/202416:15GLOBECingulate Announces Closing of $7.5 Million Public Offering
2/05/202417:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2/05/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
2/02/202409:15GLOBECingulate Announces Pricing of $7.5 Million Public Offering
1/29/202417:01EDGAR2Form SC 13D/A - General statement of acquisition of..
1/29/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/29/202408:59EDGAR2Form S-1/A - General form for registration of securities..
1/29/202408:05EDGAR2Form 8-K - Current report
1/29/202408:00GLOBELongtime Cingulate Controller Jennifer Callahan Promoted to..
1/29/202406:45GLOBEWerth Family Investment Associates Converts Remaining $3.3M..
1/12/202417:03EDGAR2Form S-1 - General form for registration of securities under..
1/04/202417:15EDGAR2Form SC 13D/A - General statement of acquisition of..
1/02/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/28/202306:02EDGAR2Form 8-K - Current report
12/15/202308:55EDGAR2Form 8-K - Current report
12/12/202317:00EDGAR2Form 8-K - Current report
12/06/202309:00EDGAR2Form RW - Registration Withdrawal Request
12/01/202309:00GLOBECingulate Receives Guidance from FDA on Path Forward for..
11/28/202308:45EDGAR2Form 8-K - Current report
11/15/202309:00EDGAR2Form S-1 - General form for registration of securities under..
11/13/202316:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202316:15GLOBECingulate Inc. Reports Third Quarter 2023 Financial..
11/03/202316:15EDGAR2Form 8-K - Current report
10/19/202317:00EDGAR2Form 8-K - Current report
10/17/202314:22GLOBECingulate to Host CNS Key Opinion Leader Panel in New York..
10/02/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202316:30EDGAR2Form DEF 14A - Other definitive proxy statements
9/22/202308:06EDGAR2Form PRE 14A - Other preliminary proxy statements
9/21/202313:30GLOBECingulate Inc. to Present at the LD Micro Main Event XVI
9/18/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/18/202317:00EDGAR2Form SC 13D/A - General statement of acquisition of..
9/18/202317:00EDGAR2Form SC 13D/A - General statement of acquisition of..
9/13/202316:15GLOBECingulate Announces Closing of $4.0 Million Public Offering
9/12/202316:05EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]

Your Recent History

Delayed Upgrade Clock